Julie Birashk
About Julie Birashk
Julie Birashk is the Associate Director, Principal Product Quality Lead for Cell Therapy Global Product Quality at Bristol Myers Squibb in Seattle, Washington, with over 20 years of experience in the biotechnology and pharmaceutical industries.
Title and Current Role
Julie Birashk is the Associate Director and Principal Product Quality Lead for Cell Therapy Global Product Quality at Bristol Myers Squibb. Based in Seattle, Washington, she oversees product quality for cell therapy, ensuring compliance with rigorous standards and contributing to the commercialization of cutting-edge therapeutics.
Professional Background
Julie Birashk has a career spanning over 20 years in the biotechnology and pharmaceutical industries. She has held various roles at companies including Bristol Myers Squibb, Juno Therapeutics, Inc., CMC ICOS Biologics, Neah Power Systems, and the National Institute for Occupational Safety and Health (NIOSH). Her positions have ranged from Intern to Process Technology Specialist to Principal Product Quality Lead, highlighting a progressive trajectory in her professional development.
Experience at Bristol Myers Squibb
Julie Birashk has been with Bristol Myers Squibb in different capacities. Before her current role, she served as Senior Manager, Principal Product Quality Lead - Global Product Quality for 7 months in 2021. Prior to that, she was Principal Process Engineer from 2020 to 2021, where she focused on process engineering and quality assurance for less than a year.
Cell Therapy and Biologics Expertise
Julie has extensive expertise in cell therapy and biologics manufacturing processes. At Juno Therapeutics, Inc., she played a pivotal role in scaling up and commercializing cell therapy products. Her work at CMC ICOS Biologics encompasses process development, technology transfer, and the implementation of Good Manufacturing Practices (GMP) in biologics production.
Educational Background
Julie Birashk holds a Bachelor of Science degree in Chemical Engineering from the University of Washington, where she studied from 1999 to 2003. Her education laid a strong foundation for her subsequent career in process optimization and quality control in the biotechnology and pharmaceutical sectors.